Rhythm Biosciences (FRA:0RY) Price-to-Operating-Cash-Flow : (As of May. 27, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Rhythm Biosciences Price-to-Operating-Cash-Flow?

As of today (2024-05-27), Rhythm Biosciences's share price is €0.04. Rhythm Biosciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.02. Hence, Rhythm Biosciences's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Rhythm Biosciences's Price-to-Operating-Cash-Flow or its related term are showing as below:

FRA:0RY's Price-to-Operating-Cash-Flow is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 17.65
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Rhythm Biosciences's Cash Flow from Operations per share for the six months ended in Dec. 2023 was €-0.01. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.02.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -10.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -10.40% per year.

During the past 6 years, Rhythm Biosciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was -6.30% per year. The lowest was -15.90% per year. And the median was -10.50% per year.

Rhythm Biosciences Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Rhythm Biosciences's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Biosciences Price-to-Operating-Cash-Flow Chart

Rhythm Biosciences Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Rhythm Biosciences Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial								-	-	-	-	-

Competitive Comparison of Rhythm Biosciences's Price-to-Operating-Cash-Flow

For the Diagnostics & Research subindustry, Rhythm Biosciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rhythm Biosciences's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Rhythm Biosciences's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Rhythm Biosciences's Price-to-Operating-Cash-Flow falls into.

Rhythm Biosciences Price-to-Operating-Cash-Flow Calculation

Rhythm Biosciences's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.04	/	-0.022
	=

Rhythm Biosciences's Share Price of today is €0.04.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Rhythm Biosciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.02.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Rhythm Biosciences Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Rhythm Biosciences's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhythm Biosciences (FRA:0RY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Rhythm Biosciences Ltd (FRA:0RY) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

RHY:Australia

Address

30 Flemington Road, Bio21 Institute, Parkville, Melbourne, VIC, AUS, 3010

Website

https://www.rhythmbio.com

Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. Geographically, the company operates only in Australia.

Rhythm Biosciences (FRA:0RY) Headlines

No Headlines